H2020-JTI-IMI2-2020-21-single-stage

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• AIT1 coordinated
• EXVASTAT LTD1 coordinated
• GeneFirst Ltd.1 coordinated
• INSERM1 coordinated
• SVA1 coordinated
• UMC UTRECHT1 coordinated
• AMU1 coordinated
• UNIVERSITEIT MAASTRICHT1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• AMU2 projects · FR
• INSERM TRANSFERT SA2 projects · FR
• INMI2 projects · IT
• TPIZ2 projects · CH
• AIT1 projects · AT
• EXVASTAT LTD1 projects · UK
• GeneFirst Ltd.1 projects · UK
• INSERM1 projects · FR
• SVA1 projects · SE
• UMC UTRECHT1 projects · NL

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• INSERM TRANSFERT SA2 projects · company
• TPIZ2 projects · company
• EXVASTAT LTD1 projects · sme
• GeneFirst Ltd.1 projects · sme
• ABBVIE INC1 projects · company
• AI-BIOPHARMA1 projects · sme
• AICURIS ANTI-INFECTIVE CURES1 projects · company
• APEIRON BIOLOGICS AG1 projects · sme
• YAMANOUCHI EUROPE BROCADES PHARMA1 projects · company
• AVA AG1 projects · sme
• AVA1 projects · sme
• BG Research Ltd1 projects · sme

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 7.5 · avg 12.88

range 5 – 43 organisations

Country spread (sample)

16 countries

5–10 partner organisations (from median 7.5 in this call’s projects) · 16 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• CARE€36,559,186
• DRAGON€11,381,970
• COVID-RED€9,592,029
• MAD-CoV 2€3,749,669
• Impentri€3,662,963
• DECISION€3,435,100
• RAPID-COVID€2,832,585
• KRONO€784,470